|
| Status |
Public on Dec 31, 2010 |
| Title |
Allelic status: HCC1008 |
| Sample type |
genomic |
| |
|
| Source name |
DNA from breast cancer cell line
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: HCC1008
catalog number: ATCC# CRL-2320
|
| Treatment protocol |
standard Affymetrix protocol
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
standard Affymetrix protocol
|
| Label |
standard Affymetrix protocol
|
| Label protocol |
standard Affymetrix protocol
|
| |
|
| Hybridization protocol |
standard Affymetrix protocol
|
| Scan protocol |
standard Affymetrix protocol
|
| Description |
Data obtained from caBIG (https://cabig.nci.nih.gov)
HCC1008
|
| Data processing |
Analyzed using dChip with the reference genotypes of sixty individuals obtained from the dChip website
|
| |
|
| Submission date |
Apr 14, 2010 |
| Last update date |
Aug 19, 2016 |
| Contact name |
Raj Chari |
| E-mail(s) |
rchari@bccrc.ca
|
| Organization name |
BC Cancer Research Centre
|
| Department |
Cancer Genetics and Developmental Biology
|
| Lab |
Wan Lam Lab
|
| Street address |
675 West 10th Avenue
|
| City |
Vancouver |
| State/province |
BC |
| ZIP/Postal code |
V5Z 1L3 |
| Country |
Canada |
| |
|
| Platform ID |
GPL3718 |
| Series (2) |
| GSE21347 |
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: allelic status |
| GSE21541 |
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer |
|
| Relations |
| Reanalyzed by |
GSE85838 |
